At the Benzinga Cannabis Capital Conference in Florida, Cresco Labs' CEO Charlie Bachtell expressed optimism about cannabis rescheduling and industry reform, highlighting the process it's undergoing and the significance of Health and Human Services' acknowledgment of cannabis' medicinal value. Bachtell discussed the political landscape, the SAFER Banking Act, and envisioned a domino effect of positive developments for cannabis policy in the U.S. following rescheduling. He addressed investor concerns, emphasizing the commitment of legislative leaders to cannabis reform.